Navigation Links
Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
Date:6/13/2008

- Efficacy and safety profile in large randomized Phase III study consistent with landmark IRIS trial, which established Gleevec as standard

of care - Study did not meet primary endpoint at 1 year, yet shows faster time to

molecular responses with 800 vs. 400 mg dose - Findings reinforce that monitoring blood levels of Gleevec may help

optimize treatment benefit for individual patients - Novartis committed to improving first-line treatment through additional study follow-up and completing enrollment to Tasigna vs. Gleevec trial

EAST HANOVER, N.J., June 13 /PRNewswire/ -- New data from a large, international clinical trial find that patients with newly diagnosed chronic myeloid leukemia who received Gleevec(R) (imatinib meslyate) tablets at 800 mg/day as their initial treatment achieved clinical milestones significantly faster than those receiving the standard 400 mg/day dose.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/novartis/33488/

The Tyrosine Kinase Inhibitor Optimization and Selectivity Study (TOPS) is the first Phase III, randomized, controlled clinical trial designed to evaluate the potential benefits of an 800 mg starting dose across all risk categories of newly diagnosed, previously untreated patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).

Numerically, more patients achieved a major molecular response (MMR) with the 800 mg dose than the 400 mg dose (46.4% vs. 40.1%); however, the difference between the two arms -- the primary endpoint of the study -- was not statistically significant. This trend of improved MMR rate at 12 months in the 800 mg vs. 400 mg arms was most pronounced in the subset of patients with the highest risk for disease progression (41.1% vs. 26.2%). Further, patients in the 800 mg a
'/>"/>

SOURCE Novartis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
2. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
3. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
4. Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis
5. ChemAxon Launches Marvin and JChem Version 5: Better User Experience, Better Integration, More Flexibility and Higher Performance
6. EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes
7. Notice of Initial Distribution of Net Settlement Funds
8. Awareness of Genzymes Renvela(R) (Sevelamer Carbonate) is High, Although Uptake of this New Phosphate Binding Agent has Been Slower than Nephrologists and Renal Dietitians Initially Expected
9. QLT reports initial proof of concept data for punctal plug delivery technology
10. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
11. Ferring Initial Purchase Order and Guaranteed Letter of Credit Launches Five Year Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... Ernst & Young LLP ("EY") that it was resigning effective ... delivered to the Company on September 15, 2014 and reported ... PDL has issued the following statement in response ... of inquiries on the reason for the resignation of EY.  ...
(Date:9/17/2014)... -- The global consumption of squalene / squalane is expected ... skin-identical chemical that finds applications in various end user industries ... in other applications like high grade lubrication, and fiber coating ... players and is regionally segregated. Sophim ( France ... ( Japan ), SeaDragon Marine Oils Ltd. ( ...
(Date:9/17/2014)... TRIANGLE PARK, N.C. , Sept. 17, 2014 /PRNewswire/ ... and presentation topics that will be featured at the ... Hamner Conference Center on December 3 and 4, 2014. ... managers are invited to hear the following: ... PhD UC San Diego Skaggs School of ...
(Date:9/17/2014)... Shimadzu Scientific Instruments introduces ... which offers a powerful separation method for ... provides a new level of knowledge and ... to scientists analyzing pharmaceutical impurities, proteins, lipids, ... Comprehensive 2D-LC combines two independent separation modes ...
Breaking Biology Technology:PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 3Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3In Silico Drug Discovery Conference Announces Speakers and Topics 2In Silico Drug Discovery Conference Announces Speakers and Topics 3In Silico Drug Discovery Conference Announces Speakers and Topics 4In Silico Drug Discovery Conference Announces Speakers and Topics 5In Silico Drug Discovery Conference Announces Speakers and Topics 6In Silico Drug Discovery Conference Announces Speakers and Topics 7Shimadzu’s New Nexera-e Two Dimensional Comprehensive Liquid Chromatograph Empowers Laboratories to Separate Even the Most Complex Mixtures 2
... NEW YORK, Sept. 25 Bion Environmental Technologies,Inc. (OTC ... its patent application entitled, "Low Oxygen Organic Waste,Bioconversion System" ... and given a Standard Patent number of 2002227224. The,official ... the patent will be,in force until an expiration date ...
... for Neptune Technologies ... in FUNCTIONAL FOOD market-- ... ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) reported today,that it entered a worldwide ... with Weider Global Nutrition for the distribution,of dietary supplements and ...
... Osteotech, Inc.,(Nasdaq: OSTE ), a leader in ... today the appointment of Cato T.,Laurencin, M.D., Ph.D. to ... Directors effective September 24, 2008 and will serve on ... of Directors., Kenneth P. Fallon, III, Chairman of ...
Cached Biology Technology:Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment 2Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 2Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 3Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 4Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors 2
(Date:9/18/2014)... racial and ethnic groups describe losing eyesight as ... life, more so than other conditions including: loss ... African-Americans, 49% of non-Hispanic whites, 43% of Asians ... or ailment is the worst that could happen ... by AIDS/HIV. Hispanics and Asians ranked cancer ...
(Date:9/18/2014)... algal forests in the eastern Mediterranean Sea pose a ... distribution continues to expand as the climate warms, a ... of researchers led by Dr Adriana Vergs of UNSW ... for Advanced Studies in Spain, is published in the ... surveyed more than 1000 kilometres of coastline in Turkey ...
(Date:9/18/2014)... that when people are too stressed they are often ... Brain Mind Institute (BMI) at EPFL have just highlighted ... chronic stress and the loss of social skills and ... a synaptic regulatory molecule in the brain. This was ... . , Carmen Sandi,s team went to look ...
Breaking Biology News(10 mins):Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3Tropical fish a threat to Mediterranean Sea ecosystems 2How stress tears us apart 2
... Antonio Medical mycologists in The South Texas Center ... Biology at The University of Texas at San Antonio ... Valley Fever, a respiratory infection of humans, commonly called ... fungus. For the first time, the researchers ...
... is based on detecting short, repetitive DNA segments in ... such characteristic repeats. "With this method we are able ... genetic relationships. Furthermore, we can show how new pathogenic ... The results have now been published in the current ...
... New Orleans residents were told to evacuate days before the ... real extent of the devastation. Now researchers from ... reliable way to help predict the intensity of the next ... States. Their model, which analyzes cell phone signals, adds a ...
Cached Biology News:UTSA infectious disease researchers advancing vaccine against Valley fever 2The tiny difference in the genes of bacteria 2Hurricane Katrina: Phone home 2
... DIGIVIEW line of digital x-ray detectors from ... device complete with 12 to 16 bit ... of a photodiode array sensor with pixel ... are available in low x-ray energies (10-50 ...
The Odyssey Infrared Imaging System is a complete family of products that includes the Odyssey Imager, IRDye labeling reagents and Odyssey software for scan control and data analysis....
... System from KUBTEC is a dual capability system ... dimensional representation of the specimen under test. While ... X-ray images, the micro focus source also allows ... in standard 2D images. The 50 mm x ...
... the condition in which a lack of ... the various antioxidants. Oxidative stress appears ... several diseases, including artherosclerosis, chronic inflammatory diseases, ... antioxidant systems that are very important for ...
Biology Products: